ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

How Cancer Control Grants, Contracts Distributed By States

October 13, 1978

Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session

November 16, 2012

ASCO President David Johnson to oncologists: It’s time to “reconnect to our patients” and “recommit to our profession.” Horning outlines priorities.

May 20, 2005

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

MAP Says It Will Continue Operating With Private Funds

April 18, 1986